Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00718445
What this trial is testing

Pennsylvania Consortium: Clinical Database

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Large-scale testing (Phase 3)Study completedNCT00056524
What this trial is testing

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Who this might be right for
Alzheimer's DiseaseStrokeParkinson's Disease+1 more
Avanir Pharmaceuticals 600
Not applicableUnknownNCT05951556
What this trial is testing

Telehealth Implementation of Brain-Computer Interface

Who this might be right for
Amyotrophic Lateral SclerosisStroke
Shirley Ryan AbilityLab 7
Testing effectiveness (Phase 2)Study completedNCT03456882
What this trial is testing

The Effect of RNS60 on ALS Biomarkers

Who this might be right for
Amyotrophic Lateral Sclerosis
Mario Negri Institute for Pharmacological Research 147
Large-scale testing (Phase 3)Ended earlyNCT01622088
What this trial is testing

Phase 3 Extension Study of Dexpramipexole in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 616
Not applicableStudy completedNCT04719403
What this trial is testing

Determining Feasibility and Acceptability of Sharing Video Recordings With Patients With ALS and Caregivers

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 79
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Study completedNCT03491462
What this trial is testing

Arimoclomol in Amyotropic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
ZevraDenmark 245
Large-scale testing (Phase 3)Looking for participantsNCT04220190
What this trial is testing

RAPA-501 Therapy for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Rapa Therapeutics LLC 41
Not applicableLooking for participantsNCT06219759
What this trial is testing

Reinnervation and Neuromuscular Transmission in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Aarhus 120
Large-scale testing (Phase 3)Looking for participantsNCT07322003
What this trial is testing

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Prilenia 500
Not applicableTemporarily Not AvailableNCT06408727
What this trial is testing

Intermediate Expanded Access Protocol CNMAu8.EAP04

Who this might be right for
ALSAmyotrophic Lateral SclerosisPALS
Clene Nanomedicine
Testing effectiveness (Phase 2)Study completedNCT03427086
What this trial is testing

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
American University of Beirut Medical Center 12
Large-scale testing (Phase 3)UnknownNCT03800524
What this trial is testing

Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Humanitas Mirasole SpA 337
Not applicableActive Not RecruitingNCT07796776
What this trial is testing

The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition

Who this might be right for
Inclusion Body Myositis (IBM)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
IRCCS San Raffaele 30
Testing effectiveness (Phase 2)Study completedNCT00326625
What this trial is testing

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Teva Pharmaceutical Industries, Ltd. 366
Not applicableStudy completedNCT00809224
What this trial is testing

Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
University of Michigan 92
Early research (Phase 1)Study completedNCT04557410
What this trial is testing

Open Label Study: Treatment of ALS Fatigue With PolyMVA

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Missouri-Columbia 12
Testing effectiveness (Phase 2)Study completedNCT01378676
What this trial is testing

Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 49
Not applicableLooking for participantsNCT06820008
What this trial is testing

Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neurone Disease
University of Dublin, Trinity College 60
Next Page